Bioadaptives Inc 's

• BDPT's Stock Performance relative to its Competitors

Amarin Corp Plcuk Share Performance -7.44% One Year

Amarin Corp Plcuk Profile Amarin Corp Plcuk's business model revolves around the development, commercialization, and marketing of innovative pharmaceutical products, particularly focused on cardiovascular health. More about Amarin Corp Plcuk's Market Share

Vivosim Labs Inc Share Performance -78.19% This Quarter

Vivosim Labs Inc Profile The company supports external clinical development and conducts drug discovery and research and development programs. More about Vivosim Labs Inc 's Market Share

Tonix Pharmaceuticals Holding Corp Share Performance -15.77% This Year

Tonix Pharmaceuticals Holding Corp Profile Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing and commercializing innovative therapies for psychiatric and neurological conditions. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials to evaluate their efficacy and safety, and ultimately obtaining regulatory approval for their products to bring them to market. Through strategic partnerships and collaborations, they aim to commercialize and distribute their therapies to provide much-needed treatment options for patients. More about Tonix Pharmaceuticals Holding Corp 's Market Share

Ocular Therapeutix Inc Share Performance -3.91% Over The Past 5 Days

Ocular Therapeutix Inc Profile Ocular Therapeutix Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for diseases and conditions of the eye. They utilize their proprietary hydrogel technology to design and manufacture sustained-release treatments that can be administered during routine eye exams and eliminate the need for patient compliance with eye drops. More about Ocular Therapeutix Inc 's Market Share

Lipocine Inc Share Performance -2.97% This Quarter

Lipocine Inc Profile Lipocine Inc is a pharmaceutical company focused on developing oral drug delivery systems for hormone therapeutics. Their business model involves conducting research and development to create innovative products that address unmet medical needs in areas such as testosterone replacement therapy and hypogonadism. The company aims to commercialize these proprietary drug candidates and collaborate with industry partners to enhance their potential reach and impact. More about Lipocine Inc 's Market Share

Sources: Bioadaptives Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 1, 2026 4:03 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bioadaptives Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.